Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency | MicrobiomeTrials← Back to trialsNCT06948214
Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency
RecruitingPHASE3INTERVENTIONAL
Trial Details
Start: 2026-05-20Est. Completion: 2027-12
Enrollment target: 150 participants Locations- Lumos Pharma Investigational Site, Birmingham, Alabama, United States
- Lumos Pharma Investigational Site, Madera, California, United States
- Lumos Pharma Investigational Site, Orange, California, United States
- Lumos Pharma Investigational Site, Sacramento, California, United States
- Lumos Pharma Investigational Site, San Diego, California, United States
- Lumos Pharma Investigational Site, Centennial, Colorado, United States
- Lumos Pharma Investigational Site, Greenwood Village, Colorado, United States
- Lumos Pharma Investigational Site, Washington D.C., District of Columbia, United States
- Lumos Pharma Investigational Site, Hollywood, Florida, United States
- Lumos Pharma Investigational Site, Jacksonville, Florida, United States
- Lumos Pharma Investigational Site, Miami, Florida, United States
- Lumos Pharma Investigational Site, Orlando, Florida, United States
- Lumos Pharma Investigational Site, Tallahassee, Florida, United States
- Lumos Pharma Investigational Site, Indianapolis, Indiana, United States
- Lumos Pharma Investigational Site, Iowa City, Iowa, United States
Other microbiome trials you might be interested in
Growth Hormone DeficiencyTraumatic Brain Injury
The goal of this observational study is to characterize the impact of growth hormone deficiency (GHD) on quality of life…
Calgary, CanadaEst. completion Mar 1, 2028
Basal Ganglia GerminomaDiabetes InsipidusGerminomaPineal Region GerminomaSuprasellar GerminomaThalamic Germinoma
This phase II trial studies how well lower dose radiotherapy after chemotherapy (Carboplatin \& Etoposide) works in trea…
Mobile, United States
Lumos Pharma Investigational Site, New Orleans, Louisiana, United StatesLumos Pharma Investigational Site, Minneapolis, Minnesota, United StatesLumos Pharma Investigational Site, Kansas City, Missouri, United StatesLumos Pharma Investigational Site, Las Vegas, Nevada, United StatesLumos Pharma Investigational Site, New Brunswick, New Jersey, United StatesLumos Pharma Investigational Site, Staten Island, New York, United StatesLumos Pharma Investigational Site, Columbus, Ohio, United StatesLumos Pharma Investigational Site, Oklahoma City, Oklahoma, United StatesLumos Pharma Investigational Site, Columbia, South Carolina, United StatesLumos Pharma Investigational Site, Amarillo, Texas, United StatesLumos Pharma Investigational Site, Corpus Christi, Texas, United StatesLumos Pharma Investigational Site, Fort Worth, Texas, United StatesLumos Pharma Investigational Site, San Antonio, Texas, United StatesLumos Pharma Investigational Site, Charlottesville, Virginia, United StatesLumos Pharma Investigational Site, Seattle, Washington, United StatesLumos Pharma Investigational Site, San Miguel de Tucumán, Tucumán Province, ArgentinaLumos Pharma Investigational Site, South Brisbane, Queensland, AustraliaLumos Pharma Investigational Site, Clayton, Victoria, AustraliaLumos Pharma Investigational Site, Parkville, Victoria, AustraliaLumos Pharma Investigational Site, Santiago, Santiago Metropolitan, ChileLumos Pharma Investigational Site, Mumbai, Maharashtra, IndiaLumos Pharma Investigational Site, Nashik, Maharashtra, IndiaLumos Pharma Investigational Site, Jaipur, Rajasthan, IndiaLumos Pharma Investigational Site, Madurai, Tamil Nadu, IndiaLumos Pharma Investigational Site, Chandigarh, IndiaLumos Pharma Investigational Site, Auckland, New ZealandLumos Pharma Investigational Site, Wellington, New ZealandLumos Pharma Investigational Site, Bangkok Noi, Bangkok, ThailandLumos Pharma Investigational Site, Pathumwan, Bangkok, ThailandLumos Pharma Investigational Site, Muang, Changwat Khon Kaen, ThailandLumos Pharma Investigational Site, Hat Yai, Changwat Songkhla, ThailandLumos Pharma Investigational Site, Muang, Chiang Mai, ThailandLumos Pharma Investigational Site, Liverpool, England, United KingdomLumos Pharma Investigational Site, London, England, United KingdomLumos Pharma Investigational Site, London, England, United KingdomLumos Pharma Investigational Site, Sheffield, England, United KingdomEst. completion Nov 4, 2033